> top > docs > PMC:7696151 > spans > 57113-59236 > annotations

PMC:7696151 / 57113-59236 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1669 1443-1448 Gene denotes TGF-β Gene:7039
1670 1450-1478 Gene denotes transforming growth factor-β Gene:7124
1671 1514-1519 Gene denotes TGF-β Gene:21802
1672 131-137 Species denotes people Tax:9606
1673 1124-1129 Species denotes women Tax:9606
1674 1306-1314 Species denotes patients Tax:9606
1675 1556-1560 Species denotes mice Tax:10090
1676 1990-1994 Species denotes mice Tax:10090
1677 303-306 Chemical denotes HCQ MESH:D006886
1678 765-768 Chemical denotes HCQ MESH:D006886
1679 873-876 Chemical denotes HCQ MESH:D006886
1680 1169-1172 Chemical denotes HCQ MESH:D006886
1681 1229-1232 Chemical denotes HCQ MESH:D006886
1682 1496-1499 Chemical denotes HCQ MESH:D006886
1683 1714-1717 Chemical denotes HCQ MESH:D006886
1684 1925-1928 Chemical denotes HCQ MESH:D006886
1685 7-40 Disease denotes Sjögren Syndrome Sjögren syndrome MESH:D012859
1686 47-65 Disease denotes autoimmune disease MESH:D001327
1687 176-200 Disease denotes lymphocytic inflammation MESH:D007249
1688 251-261 Disease denotes xerostomia MESH:D014987
1689 314-330 Disease denotes Sjögren syndrome MESH:D012859
1690 786-802 Disease denotes Sjögren syndrome MESH:D012859
1691 1107-1123 Disease denotes Sjögren syndrome MESH:D012859
1692 1199-1210 Disease denotes eye dryness MESH:D014987
1693 1322-1337 Disease denotes Hypo-salivation MESH:D052456
1694 1352-1366 Disease denotes acinar atrophy MESH:D018267
1695 1371-1379 Disease denotes fibrosis MESH:D005355
1696 1799-1823 Disease denotes lymphocytic infiltration MESH:D017254
1697 2008-2032 Disease denotes lymphocytic infiltration MESH:D017254

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T99 47-65 Phenotype denotes autoimmune disease http://purl.obolibrary.org/obo/HP_0002960
T100 251-261 Phenotype denotes xerostomia http://purl.obolibrary.org/obo/HP_0000217

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T366 0-6 Sentence denotes 2.3.4.
T367 7-23 Sentence denotes Sjögren Syndrome
T368 24-138 Sentence denotes Sjögren syndrome is an autoimmune disease with a strong negative impact on the quality of life of affected people.
T369 139-268 Sentence denotes The main features of the disease are lymphocytic inflammation and alterations in major salivary glands, causing xerostomia [103].
T370 269-423 Sentence denotes Even if preliminary results about HCQ use in Sjögren syndrome were not encouraging, to date it arises as one of the first-line drugs in disease treatment.
T371 424-714 Sentence denotes Indeed, an earlier prospective, a two-year double-blind crossover trial on 19 subjects correlated an annual intake of a dose of 400 mg/day with no significant improvements in clinical symptoms and signs of pathology, including tear and salivary gland activity, respect to the placebo [121].
T372 715-826 Sentence denotes However, a few years later, the first evidence of HCQ effectiveness in Sjögren syndrome treatment was reported.
T373 827-1060 Sentence denotes Annual treatment with a dose of 200 mg/day of HCQ showed anti-lymphoproliferative and anti-inflammatory effects, with a reduction of IgG and IgA immunoglobulins, anti-Sjögren autoantibodies, and erythrocyte sedimentation rates [100].
T374 1061-1321 Sentence denotes Moreover, the salivary flow rate increased in Sjögren syndrome women who received a daily dose of 400 mg of HCQ for 30 weeks [101], while eye dryness was alleviated by HCQ administration (6.5 mg/kg), as demonstrated by a prospective study on 32 patients [102].
T375 1322-1480 Sentence denotes Hypo-salivation deriving from acinar atrophy and fibrosis of salivary glands is often associated with over-expression of TGF-β (transforming growth factor-β).
T376 1481-1703 Sentence denotes Treatment with HCQ downregulated TGF-β levels in a randomized trial on NOD mice exposed to doses of 50 mg/kg/day intragastrically (i.g.) for 16 weeks, with significant results in delaying loss of saliva secretory function.
T377 1704-1830 Sentence denotes Moreover, HCQ intake was also accompanied by a decrease in autoantibody production and a lower lymphocytic infiltration [103].
T378 1831-2123 Sentence denotes These findings were confirmed by Wu, Pu, Yu and Li [104], showing that 8-weeks treatment with HCQ administered at a dose of 60 mg/kg i.g. in 40 randomized NOD mice led to lower lymphocytic infiltration, with a significant improvement in pathological changes in submandibular gland morphology.